• Hikma Pharma Launches Outsourced Sterile Compounding Business - Quick Facts

    Source: NASDAQ US Markets / 10 Jan 2022 02:48:45   America/New_York

    (RTTNews) - Hikma Pharmaceuticals PLC (HIK, HIK.L) has launched Hikma 503B, a new outsourced sterile compounding business focused on providing ready-to-administer injectable medications that are customized to the specific needs of patients in the U.S. Hikma 503B is expected to be https://www.nasdaq.com/articles/hikma-pharma-launches-outsourced-sterile-compounding-business-quick-facts
Share on,